Replies to post #9570 on Sorrento Therapeutics Inc (SRNE)

[Jesspro]

1776, love your posts. You gave them hopes but only to get diarrhea in the last bold line, lol.

[Brandywhitneylady]

Regeneron CEO on CNBC discussing how effective their antibody is, including prevention. Thanks Dr. Ji.

ZURICH (Reuters) -Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is ill, the U.S. drugmaker said on Monday.

REGEN-COV, a combination of casirivimab and imdevimab, protected household contacts from exposure to SARS-CoV-2, with 72% protection against symptomatic infections in the first week, and 93% after that, according to trial data released by the company.